PepFinder
GLP-1 receptor agonistGLP-1 Agonists

Liraglutide

A once-daily GLP-1 receptor agonist with 97% homology to native GLP-1. FDA-approved as Victoza (diabetes) and Saxenda (obesity). First GLP-1 RA approved for weight management. Generic available since 2025.

weight-lossblood-sugar-controlappetite-suppressionFDA-approved
3D Structure
3D Structure
3751.2 Da
Molecular Weight3,751.2 Da
FormulaC172H265N43O51
PubChem CID16134956
Lab Tested
No
Harmful Ingredients
0
Contaminants
None
Tested Purity
--
Batch Consistency
No batch data
Mass Spec Profile
Intensity18762350282432993773m/z3751.0
ESI-MS (computed)
Batch Info
Latest Batch—
Total Tests0
Unique Vendors0
Vendor Comparison
No vendor data yet
Analysis Summary
Purity Standard
No purity data
Lab Reports
0 reports on file
Summary

A once-daily GLP-1 receptor agonist with 97% homology to native GLP-1. FDA-approved as Victoza (diabetes) and Saxenda (obesity). First GLP-1 RA approved for weight management. Generic available since …